DNA Vaccines pp 241-249 | Cite as

The Use of Conventional Immunologic Adjuvants in DNA Vaccine Preparations

  • Shin Sasaki
  • Kenji Okuda
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 29)


The term “adjuvant” originates from the Latin word adjuvare, which means to help or aid. An immunologic adjuvant is defined as any substance that acts to accelerate, prolong, or enhance antigen-specific immune responses when used in combination with specific vaccine antigens (1). In a broad sense, immunologic adjuvants include certain cytokines and other immunomodulatory molecules (i.e. chemokines and costimulatory factors) or their expression vectors. Since these adjuvants are described elsewhere in this book, here, we are concerned only with adjuvants that are derived from microorganisms and plants or are synthesized chemically.


HEPES Buffer Vortex Mixer Cationic Liposome Monophosphoryl Lipid Immunologic Adjuvant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Vogel, F. R. (1995) Immunologic adjuvants for modern vaccine formulations, in Combined Vaccine and Simultaneous Administration—Current Issues and Perspectives, Ann. NY Acad. Sci., vol. 754 (Williams, J. C., Goldenthal, K. L., Burns, D. L., and Lewis, B. P. J., eds.) N Y Academy of Sciences, New York. pp. 153–160.Google Scholar
  2. 2.
    Powell, M. F. and Newman, M. J., eds. (1995) Vaccine Design: The Subunit and Adjuvant Approach, Plenum Press, New York.Google Scholar
  3. 3.
    Golding, B. and Scott, D. E. (1995) Vaccine Strategies: Targetting helper T cell responses, in Combined Vaccine and Simultaneous Administration—Current Issues and Perspectives, Ann. NY Acad. Sci. vol. 754 (Williams, J. C., Goldenthal, K. L., Burns, D. L., and Lewis, B. P. J., eds.) NY Academy of Sciences, New York. pp. 126–137.Google Scholar
  4. 4.
    Gupta, R. K. and Siber, G. R. (1995) Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13, 1263–1276.PubMedCrossRefGoogle Scholar
  5. 5.
    Corr, M., Lee, D. J., Carson, D. A., and Tighe, H. (1996) Gene vaccination with naked plasmid DNA: Mechanism of CTL priming. J. Exp. Med. 184, 1555–1560.PubMedCrossRefGoogle Scholar
  6. 6.
    Doe, B., Selby, M., Barnett, S., Baenziger, J., and Walker, C. M. (1996) Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93, 8578–8583.PubMedCrossRefGoogle Scholar
  7. 7.
    Tsuji, T., Fukushima, J., Hamajima, K., Ishii, N., Aoki, I., Xin, K.-Q., et al. (1997) HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine. Immunology 90, 1–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Sasaki, S., Tsuji, T., Hamajima, K., Fukushima, J., Ishii, N., Kaneko, T., et al. (1997) Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against Human Immunodeficiency Virus Type 1. Infect. Immun. 65, 3520–3528.PubMedGoogle Scholar
  9. 9.
    Sasaki, S., Sumino, K., Hamajima, K., Fukushima, J., Ishii, N., Kawamoto, S., et al. (1998) Induction of systemic and mucosal immune responsees to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes. J. Virol. 72, 4931–4939.PubMedGoogle Scholar
  10. 10.
    Kuklin, N., Daheshia, M., Karem, K., Manickan, E., and Rouse, B. T. (1997) Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71, 3138–3145.PubMedGoogle Scholar
  11. 11.
    Watanabe, A., Raz, E., Kohsaka, H., Tighe, H., Baird, S. M., Kipps, T. J., and Carson, D. A. (1993) Induction of antibodies to a kappa V region by gene immunization. J. Immunol. 151, 2871–2876.PubMedGoogle Scholar
  12. 12.
    Xiang, Z. Q., and Ertl, H. C. J. (1995) Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2, 129–135.PubMedCrossRefGoogle Scholar
  13. 13.
    Tsuji, T., Hamajima, K., Fukushima, J., Xin, K.-Q., Ishii, N., Aoki, I. (1997) Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J. Immunol. 158, 4008–4014.PubMedGoogle Scholar
  14. 14.
    Iwasaki, A., Stiernholm, B. J. N., Chan, A. K., Berinstein, N. L., and Barber, B. H. (1997) Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158, 4591–4601.PubMedGoogle Scholar
  15. 15.
    Gregoriadis, G., Saffie, R., and de Souza, J. B. (1997) Liposome-mediated DNA vaccination. FEBS Lett. 402, 107–110.PubMedCrossRefGoogle Scholar
  16. 16.
    Ishii, N., Fukushima, J., Kaneko, T., Okada, E., Tani, K., Tanaka, S.-I., et al. (1997) Cationic liposomes are a strong adjuvant of DNA vaccine for a Human Immunodeficiency Virus Type-1 (HIV-1). AIDS Res. Hum. Retroviruses 13, 1421–1428.PubMedCrossRefGoogle Scholar
  17. 17.
    Gao, X. and Huang, L. (1991) A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Comm. 179, 280–285.PubMedCrossRefGoogle Scholar
  18. 18.
    Toda, S., Ishii, N., Okada, E., Kusakabe, K.-I., Arai, H., Hamajima, K., et al. (1997) HIV-1 specific cell-mediated immune responses induced by DNA vaccination are enhanced by mannan-coated liposomes and inhibited by anti-inter-feron (IFN)-gamma antibody. Immunology 92, 111–117.PubMedCrossRefGoogle Scholar
  19. 19.
    Sasaki, S., Fukushima, J., Arai, H., Kusakabe, K., Hamajima, K., Ishii, N., et al. (1997) Human immunodeficiency virus type 1 specific immune response induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine. Eur. J. Immunol. 27, 3121–3129.PubMedCrossRefGoogle Scholar
  20. 20.
    Sugimoto, M., Ohishi, K., Fukasawa, M., Shikata, K., Kawai, H., Itakura, H., et al. (1995) Oligomannose-coated liposomes as an adjuvant for the induction of cell-mediated immunity. FEBS Lett. 363, 53–56.PubMedCrossRefGoogle Scholar
  21. 21.
    Wang, S., Manning, S., Kensil, C. R., and Lu, S. (1997) QS-21 is effective in boosting anti-HIV-1 Env antibody responses induced by DNA immunization. 9th Annual Meeting of The National Cooperative Vaccine Development Groups for AIDS, poster abstract 15. Bethesda, MD, USA.Google Scholar
  22. 22.
    Sasaki, S., Hamajima, K., Fukushima, J., Tsuji, T., Xin, K.-Q., Ishii, N., et al. (1997) Adjuvant effect of ubenimex on a DNA vaccine for human immunodeficiency virus type-1. Clin. Exp. Immunol. 111, 30–35.CrossRefGoogle Scholar
  23. 23.
    Hamajima, K., Sasaki, S., Fukushima, J., Kaneko, T., Xin, K.-Q., Kudo, I., and Okuda, K. (1998) Intranasal administration of HIV-DNA vaccine formulated with a polymer, carboxymethyl cellulose augment mucosal antibody production and cell-mediated immune response. Clin. Immunol. Immunopathol. 80, 205–210.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2000

Authors and Affiliations

  • Shin Sasaki
    • 1
  • Kenji Okuda
    • 2
  1. 1.Division of Microbiology and Immunology, Yerkes Primate Research CenterEmory UniversityAtlanta
  2. 2.Department of BacteriologyYokohama City University School of MedicineYokohamaJapan

Personalised recommendations